Keywords
smoking cessation
harm reduction
How to Cite
Abstract
The usual approach to the treatment of smoking to set a date to stop smoking abruptly has been refuted by many patients who show interest in reducing their consumption gradually. The progressive reduction using nicotine replacement therapy prior to cessation would treat a greater number of smokers. It’s the case of a patient with high nicotine dependence, interested in quitting but not abruptly.
US Department of Health and Human Services. The health consequences of smoking: A report of the surgeon general. Atlanta, (GA): U.S. Department of Health and Human Services, Centers for Diseases Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
World Health Organization. Report on the global tobacco epidemic. Switzerland: WHO; 2011.
U.S. Department of Health and Human Services. The health consequences of smoking—50 years of progress: A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014. Printed with corrections, January 2014.
American Cancer Society and World Lung Foundation. The Tobacco Atlas. 2015.
Pichon A, Bardach A, Caporale J, Augustovski F, Alcaraz A, Navia M, et al. Health and economic burden of tobacco use in seven Latin American countries: Results from a microsimulation Health Economic Model (HEM). Value in Health 16. 2013:A665–A728.
Fiore MC, Jaén CR, Baker TB, Bailey WC. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2008.
Organización Mundial de la Salud. Strengthening health systems for treating tobacco dependence in primary care. Part 1: Training forpolicy. Washington: OMS; 2013.
Aveyard P, Raw M. Improving smoking cessation approaches at the individual level. Tob Control [internet]. 2012;21(2):252-57. Disponible en: http://tobaccocontrol.bmj.com/content/21/2/252.full
Alba LH, Murillo R, Becerra N, Páez N, Cañas A, Mosquera Ca, Castillo JS, Camacho N, Gómez J, García-Herreros P, Bernal LG. Recomendaciones para la cesación de la adicción al tabaco en Colombia. Biomédica. 2013;33:186-204.
Guichenez P, Clauzel I, Cungi C, et al. The contribution of cognitive-behavioural therapies to smoking cessation [in French]. Rev Mal Respir. 2007;24(2):171-82.
Fernández Arias I. Eficacia de la terapia cognitivo conductual, los parches de nicotina y su combinación para dejar de fumar. Tesis Doctoral, Universidad Complutense de Madrid, España; 2012.
Becoña E, Fernández del Río E, López A, Martínez U, Martínez C, Rodríguez RA. El tratamiento psicológico de la dependencia del tabaco: Eficacia, barreras y retos para el futuro. Papeles del Psicólogo. 2014;35(3):161-8.
Encuesta Millward Brown. Mayo 2006. Barcelona.
Fagerström KO. Interventions for treatment-resistant smokers. Nicotine Tob Res. 1999;1:S201-5.
Fagerström KO. Can reduced smoking be a way for smokers not interested in quitting to actually quit? Respiration. 2005;72:216-20.
Ebbert JO, Hughes JR, West RJ, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomised clinical trial. JAMA. 2015;313:687-94.
Jiménez Ruiz CA, Fagerström KO. Reducción hasta dejarlo: árbol de decisión. Prev Tab. 2006;8(Supl. 1):34-7.
Hughes JR, Carpenter MJ. The feasibility of smoking reduction: an update. Addiction. 2005;100:1074-89.
Wennike P, Danielsson T, Landfeldt B, Westin A, Tonnesen P. Smoking reduction promotes smoking cessation: results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction. 2003;98:1395-1402.
Batra A, Klingler K, Landfeldt B, Friederich HM, Westin A, Danielsson T. Smoking reduction treatment with 4-mg nicotine gum: A double-blind, randomized, placebo-controlled study. Clin Pharmacol Ther. 2005;78:689-96.
Rennard SI, Glover E, Leischow S, Daughton DM, Glover P, Muramoto M, Franzon M, Danielsson T, Landfeldt B, Westin A. Efficacy of nicotine inhaler in smoking reduction: a double-blind, randomized trial. Nicotine Tob Res. 2006;8:555-64.
Kralikova E, Kozak J, Rasmussen T, et al. Smoking cessation or reduction with nicotine replacement therapy: A placebo-controlled double blind trial with nicotine gum and inhaler. BMC Public Health. 2009;9:433.
Wennike P, Danielsson T, Landfeldt B, Westin A, Tønnesen P. Smoking reduction promotes smoking cessation: results from a double blind, randomised, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction. 2003;98:1395-1402.
Glasgow RE, Gaglio B, France EK, Marcus Al, Riley KM. et al. Do behavioural smoking reduction approaches reach more or different smokers?: Two studies similar answers. Add Beh. 2006;31:510-8.
Hughes JR, Callas PW, Peters EN. Interest in gradual reduction. Nic Tob Res. 2007;6:671-5.
Stead LF, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Systems Review. 2007;18(3):CD 005231.
Sophia SC, Chan D. Leung A, Abdullah V, Wong A, Hedley L. A randomized controlled trial of a smoking reduction plus nicotine replacement therapy intervention for smokers not willing to quit smoking. Addiction. 106;1155-63.add
Jiménez Ruiz CA, Riesco Miranda JA, Ramos Pinedo A, Barrueco Ferrero M, Solano Reina S, de Granda Orive JI, et al. Recomendaciones para el tratamiento farmacológico del tabaquismo: propuesta de financiación. Arch Bronconeumol. 2008;44(4):213-9.
Fagerström KO, Hughes RJ. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A review. Nic Tob Res. 2002;4:S155-61.
Lindson-Hawley N, Hartmann-Boyce J, Fanshawe T, Begh R, Farley A, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database. Octubre, 2016.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.